Related Experiment Video
Updated: Apr 5, 2026

The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
The Vulnerable Ventral Tegmental Area in Parkinson's Disease
Stephanie L Alberico1, Martin D Cassell2, Nandakumar S Narayanan1
1Department of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United States.
Introduction:
The involvement of dopaminergic neurons in the ventral tegmental area (VTA) in Parkinson's disease (PD) has not been universally recognized by neuroscientists and neurologists. Here, we conduct a review of previous research documenting dopaminergic neuronal loss in both the substantia nigra pars compacta (SNpc) and VTA and add three new post-mortem PD cases to the literature.
Methods:
PD and control brains were sectioned, stained for tyrosine hydroxylase, and cells in the SNpc and VTA were counted.
Results:
Based on the review, we report two main results: 1) the VTA does degenerate in PD, and 2) the VTA degenerates less than the SNpc.
Conclusion:
Inconsistent clinical information about these cases limits our ability to interpret how the VTA contributes to PD symptoms. However, our data in combination with prior PD neuropathological cases in the literature unequivocally establish that the VTA is involved in PD, and could be relevant for future investigation of non-motor symptoms in PD.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Neural Regulation

